FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2075532113> ?p ?o ?g. }

• W2075532113 endingPage "1082" @default.
• W2075532113 startingPage "1071" @default.
• W2075532113 abstract "Irinotecan is a water-soluble camptothecin derivative with clinical activity against colorectal and small cell lung cancers and is currently a standard of care therapeutic in the treatment of colorectal cancer in combination with 5-fluorouracil. One of the major clinical issues limiting the use of irinotecan is gastrointestinal toxicity manifested as life-threatening diarrhea which is reported in up to 45% of treated patients. The studies summarized here tested, in a rat model of irinotecan-associated gastro-intestinal toxicity, whether a lipid nanoparticle formulation of irinotecan, Irinophore C™, mitigated early-onset or late-onset diarrhea when given at doses equivalent to unformulated irinotecan that engenders both early- and late-onset diarrhea. Specifically, rats administered intravenously on two consecutive days with unformulated irinotecan at 170 mg/kg then 160 mg/kg experienced transient early-onset diarrhea after each administration and then experienced significant late-onset diarrhea peaking 4 days after treatment. Irinophore C™ given at the identical dose and schedule did not elicit either early- or late-onset diarrhea in any animals. When Irinophore C™ was combined with 5-fluorouracil there was also no early- or late-onset diarrhea observed. Histopathological analysis of the gastro-intestinal tract confirmed that the effects associated with irinotecan treatment were absent in rats given Irinophore C™ at the identical dose. Pharmacokinetic analysis demonstrated significantly higher systemic concentrations of irinotecan in rats given the nanoparticle formulation compared to those given unformulated irinotecan. These results demonstrate that the Irinophore C™ formulation is significantly less toxic than irinotecan, used either as a single agent or in combination with 5-fluorouracil, in a rat model of irinotecan-induced gastrointestinal toxicity." @default.
• W2075532113 created "2016-06-24" @default.
• W2075532113 creator A5007749797 @default.
• W2075532113 creator A5025988193 @default.
• W2075532113 creator A5032785412 @default.
• W2075532113 creator A5033122071 @default.
• W2075532113 creator A5036143759 @default.
• W2075532113 creator A5054102422 @default.
• W2075532113 creator A5055078717 @default.
• W2075532113 creator A5060444203 @default.
• W2075532113 creator A5060931694 @default.
• W2075532113 creator A5066882813 @default.
• W2075532113 creator A5070792731 @default.
• W2075532113 creator A5071405218 @default.
• W2075532113 creator A5077901802 @default.
• W2075532113 date "2014-07-27" @default.
• W2075532113 modified "2023-10-14" @default.
• W2075532113 title "Irinophore C™, a lipid nanoparticle formulation of irinotecan, abrogates the gastrointestinal effects of irinotecan in a rat model of clinical toxicities" @default.
• W2075532113 cites W1869323251 @default.
• W2075532113 cites W1974822561 @default.
• W2075532113 cites W1975100932 @default.
• W2075532113 cites W1976626931 @default.
• W2075532113 cites W1977482169 @default.
• W2075532113 cites W1987992642 @default.
• W2075532113 cites W2000590100 @default.
• W2075532113 cites W2038765960 @default.
• W2075532113 cites W2105603202 @default.
• W2075532113 cites W2123477611 @default.
• W2075532113 cites W2125060052 @default.
• W2075532113 cites W2147302668 @default.
• W2075532113 doi "https://doi.org/10.1007/s10637-014-0138-x" @default.
• W2075532113 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4226839" @default.
• W2075532113 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25064374" @default.
• W2075532113 hasPublicationYear "2014" @default.
• W2075532113 type Work @default.
• W2075532113 sameAs 2075532113 @default.
• W2075532113 citedByCount "12" @default.
• W2075532113 countsByYear W20755321132017 @default.
• W2075532113 countsByYear W20755321132018 @default.
• W2075532113 countsByYear W20755321132019 @default.
• W2075532113 countsByYear W20755321132021 @default.
• W2075532113 countsByYear W20755321132022 @default.
• W2075532113 countsByYear W20755321132023 @default.
• W2075532113 crossrefType "journal-article" @default.
• W2075532113 hasAuthorship W2075532113A5007749797 @default.
• W2075532113 hasAuthorship W2075532113A5025988193 @default.
• W2075532113 hasAuthorship W2075532113A5032785412 @default.
• W2075532113 hasAuthorship W2075532113A5033122071 @default.
• W2075532113 hasAuthorship W2075532113A5036143759 @default.
• W2075532113 hasAuthorship W2075532113A5054102422 @default.
• W2075532113 hasAuthorship W2075532113A5055078717 @default.
• W2075532113 hasAuthorship W2075532113A5060444203 @default.
• W2075532113 hasAuthorship W2075532113A5060931694 @default.
• W2075532113 hasAuthorship W2075532113A5066882813 @default.
• W2075532113 hasAuthorship W2075532113A5070792731 @default.
• W2075532113 hasAuthorship W2075532113A5071405218 @default.
• W2075532113 hasAuthorship W2075532113A5077901802 @default.
• W2075532113 hasBestOaLocation W20755321131 @default.
• W2075532113 hasConcept C112705442 @default.
• W2075532113 hasConcept C121608353 @default.
• W2075532113 hasConcept C126322002 @default.
• W2075532113 hasConcept C2779682216 @default.
• W2075532113 hasConcept C2779802037 @default.
• W2075532113 hasConcept C2780259306 @default.
• W2075532113 hasConcept C29730261 @default.
• W2075532113 hasConcept C526805850 @default.
• W2075532113 hasConcept C55493867 @default.
• W2075532113 hasConcept C71924100 @default.
• W2075532113 hasConcept C86803240 @default.
• W2075532113 hasConcept C90924648 @default.
• W2075532113 hasConcept C98274493 @default.
• W2075532113 hasConceptScore W2075532113C112705442 @default.
• W2075532113 hasConceptScore W2075532113C121608353 @default.
• W2075532113 hasConceptScore W2075532113C126322002 @default.
• W2075532113 hasConceptScore W2075532113C2779682216 @default.
• W2075532113 hasConceptScore W2075532113C2779802037 @default.
• W2075532113 hasConceptScore W2075532113C2780259306 @default.
• W2075532113 hasConceptScore W2075532113C29730261 @default.
• W2075532113 hasConceptScore W2075532113C526805850 @default.
• W2075532113 hasConceptScore W2075532113C55493867 @default.
• W2075532113 hasConceptScore W2075532113C71924100 @default.
• W2075532113 hasConceptScore W2075532113C86803240 @default.
• W2075532113 hasConceptScore W2075532113C90924648 @default.
• W2075532113 hasConceptScore W2075532113C98274493 @default.
• W2075532113 hasIssue "6" @default.
• W2075532113 hasLocation W20755321131 @default.
• W2075532113 hasLocation W20755321132 @default.
• W2075532113 hasLocation W20755321133 @default.
• W2075532113 hasLocation W20755321134 @default.
• W2075532113 hasOpenAccess W2075532113 @default.
• W2075532113 hasPrimaryLocation W20755321131 @default.
• W2075532113 hasRelatedWork W1850727413 @default.
• W2075532113 hasRelatedWork W1940591674 @default.
• W2075532113 hasRelatedWork W2028300518 @default.
• W2075532113 hasRelatedWork W2047348737 @default.
• W2075532113 hasRelatedWork W2077935447 @default.
• W2075532113 hasRelatedWork W2083574760 @default.
• W2075532113 hasRelatedWork W2398329320 @default.

• next